Sfoglia per Autore
Aprepitant (AP) versus dexamethasone (D) for preventing delayed emesis induced by anthracyclines plus cyclophosphamide (A plus C) chemotherapy (CT) in breast cancer patients (pts): A double-blind, multicenter, randomized study
2013 Roila, F; Ballatori, E; Fabi, A; Fatigoni, S; Chiara, S; Ionta, Mt; Aieta, M; Clerico, M; Palladino, Ma; Indelli, M; Garrone, O; Bustreo, S; Ruggeri, B
Hepatitis B in immunosuppressed cancer patients:pathogenesis, incidence and prophylaxis
2013 Mandalà, M; Fagiuoli, S; Francisci, Daniela; Bruno, R; Merelli, B; Pasulo, L; Tondini, C; Labianca, R; Roila, F.; Mandala', Mario
Aprepitant Versus Dexamethasone for Preventing Chemotherapy-Induced Delayed Emesis in Patients With Breast Cancer: A Randomized Double-Blind Study
2014 Roila, F; Ruggeri, B; Ballatori, E; Del Favero, A; Tonato, M
Aprepitant versus metoclopramide, both combined with dexamethasone, for preventing cisplatin-induced delayed emesis: A randomized, double-blind study
2014 Roila, F; Ballatori, E; Ruggeri, B; Fatigoni, S; Mirabile, A; Frau, B; Cavanna, L; Fava, S; Colantonio, I; Angelelli, L; Ciuffreda, L; Lutrino, Se; Zerilli, F
Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study
2014 Molassiotis, A; Aapro, M; Dicato, M; Gascon, P; Novoa, Sa; Isambert, N; Burke, Ta; Gu, A; Roila, F
Renal malignant solitary fibrous tumor with single lymph node involvement: report of unusual metastasis and review of the literature.
2014 Mearini, Ettore; Cochetti, Giovanni; Barillaro, Francesco; Fatigoni, S; Roila, F.
Aprepitant Versus Dexamethasone for Delayed Emesis: What Is the Role of the 5-Hydroxytryptamine Type 3 Receptor Antagonist Palonosetron? Reply
2014 Roila, F; Fatigoni, S; Ballatori, E
Update on anticancer drugs
2014 Roila, F; Ballatori, E
A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients
2015 Fonte, C; Fatigoni, S; Roila, F
Optimal Management of Fatigue
2015 Roila, F
NICSO: Network Italiano Cure di Supporto in Oncologia – Italian Network for Supportive Care in Oncology
2015 Roila, F; Ripamonti, Ci; Antonuzzo, A; Bossi, P
Chemotherapy-induced nausea and vomiting
2015 Rapoport, Bl; Molasiotis, A; Raftopoulos, H; Roila, F
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: A randomized, double-blind study
2015 Roila, F; Ruggeri, B; Ballatori, E; Fatigoni, S; Caserta, C; Licitra, L; Mirabile, A; Ionta, Mt; Massidda, B; Cavanna, L; Palladino, Ma; Tocci, A; Fava, S; Colantonio, I; Angelelli, L; Ciuffreda, L; Fasola, G; Zerilli, F
A new payment-by-results method for determining the fair price of new oncological drugs
2015 Ballatori, E; Ferrante, L; Ruggeri, B; Roila, F
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
2016 Roila, F; Molassiotis, A; Herrstedt, J; Aapro, M; Gralla, Rj; Bruera, E; Clark-Snow, Ra; Dupuis, Ll; Einhorn, Lh; Feyer, P; Hesketh, Pj; Jordan, K; Olver, I; Rapoport, Bl; Roscoe, J; Ruhlmann, Ch; Walsh, D; Warr, D; van der Wetering, M
Incidence, characteristics and treatment of fatigue in oncological cancer patients (pts) in italy: a cross-section study
2016 Roila, F; Spina, F; Ripamonti, C; Fumi, G; Antonuzzo, A; Cavanna, L; Gori, S; Mirabile, A; Fabi, A; Marzano, N; Graiff, C; De Sanctis, V; Serpentini, S; Bocci, C; Pino, Ms; Clienti, G; Verusio, C; Lutrino, Se; Fatigoni, S; Ballatori, E
Anticipatory Nausea, Risk Factors, and Its Impact on Chemotherapy-Induced Nausea and Vomiting: Results From the Pan European Emesis Registry Study
2016 Molassiotis, A; Lee, Ph; Burke, Ta; Dicato, M; Gascon, P; Roila, F; Aapro, M
Ginger in the management of chemotherapy induced nausea and vomiting (CINV), in patients receiving high dose cisplatin: a multicenter, randomized, double-blind, placebo-controlled study
2016 Bergamini, C; Bergamini, C; Cortinovis, D; Fatigoni, S; Rocca, Mc; Fabi, A; Iannace, A; Emiliani, A; Pessi, Ma; Ripamonti, Ci; Alfieri, S; Granata, R; Agustoni, F; Bidoli, P; Roila, F; Nole, F; Macchi, F; Michellini, L; Montanaro, F; Bossi, P
Searching for evidence to support the use of ginger in the prevention of chemotherapy-induced nausea and vomiting
2016 Bossi, P; Cortinovis, D; Rocca, Mc; Roila, F; Seminara, P; Fabi, A; Canova, S; Verri, E; Fatigoni, S; Iannace, A; Macchi, F; Ripamonti, C
Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain
2016 Bandieri, E; Romero, M; Ripamonti, Ci; Artioli, F; Sichetti, D; Fanizza, C; Santini, D; Cavanna, L; Melotti, B; Conte, Pf; Roila, F; Cascinu, S; Bruera, E; Tognoni, G; Luppi, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Aprepitant (AP) versus dexamethasone (D) for preventing delayed emesis induced by anthracyclines plus cyclophosphamide (A plus C) chemotherapy (CT) in breast cancer patients (pts): A double-blind, multicenter, randomized study | 2013 | Roila, F; Ballatori, E; Fabi, A; Fatigoni, S; Chiara, S; Ionta, Mt; Aieta, M; Clerico, M; Palladino, Ma; Indelli, M; Garrone, O; Bustreo, S; Ruggeri, B | |
| Hepatitis B in immunosuppressed cancer patients:pathogenesis, incidence and prophylaxis | 2013 | Mandalà, M; Fagiuoli, S; Francisci, Daniela; Bruno, R; Merelli, B; Pasulo, L; Tondini, C; Labianca, R; Roila, F.; Mandala', Mario | |
| Aprepitant Versus Dexamethasone for Preventing Chemotherapy-Induced Delayed Emesis in Patients With Breast Cancer: A Randomized Double-Blind Study | 2014 | Roila, F; Ruggeri, B; Ballatori, E; Del Favero, A; Tonato, M | |
| Aprepitant versus metoclopramide, both combined with dexamethasone, for preventing cisplatin-induced delayed emesis: A randomized, double-blind study | 2014 | Roila, F; Ballatori, E; Ruggeri, B; Fatigoni, S; Mirabile, A; Frau, B; Cavanna, L; Fava, S; Colantonio, I; Angelelli, L; Ciuffreda, L; Lutrino, Se; Zerilli, F | |
| Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study | 2014 | Molassiotis, A; Aapro, M; Dicato, M; Gascon, P; Novoa, Sa; Isambert, N; Burke, Ta; Gu, A; Roila, F | |
| Renal malignant solitary fibrous tumor with single lymph node involvement: report of unusual metastasis and review of the literature. | 2014 | Mearini, Ettore; Cochetti, Giovanni; Barillaro, Francesco; Fatigoni, S; Roila, F. | |
| Aprepitant Versus Dexamethasone for Delayed Emesis: What Is the Role of the 5-Hydroxytryptamine Type 3 Receptor Antagonist Palonosetron? Reply | 2014 | Roila, F; Fatigoni, S; Ballatori, E | |
| Update on anticancer drugs | 2014 | Roila, F; Ballatori, E | |
| A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients | 2015 | Fonte, C; Fatigoni, S; Roila, F | |
| Optimal Management of Fatigue | 2015 | Roila, F | |
| NICSO: Network Italiano Cure di Supporto in Oncologia – Italian Network for Supportive Care in Oncology | 2015 | Roila, F; Ripamonti, Ci; Antonuzzo, A; Bossi, P | |
| Chemotherapy-induced nausea and vomiting | 2015 | Rapoport, Bl; Molasiotis, A; Raftopoulos, H; Roila, F | |
| Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: A randomized, double-blind study | 2015 | Roila, F; Ruggeri, B; Ballatori, E; Fatigoni, S; Caserta, C; Licitra, L; Mirabile, A; Ionta, Mt; Massidda, B; Cavanna, L; Palladino, Ma; Tocci, A; Fava, S; Colantonio, I; Angelelli, L; Ciuffreda, L; Fasola, G; Zerilli, F | |
| A new payment-by-results method for determining the fair price of new oncological drugs | 2015 | Ballatori, E; Ferrante, L; Ruggeri, B; Roila, F | |
| 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients | 2016 | Roila, F; Molassiotis, A; Herrstedt, J; Aapro, M; Gralla, Rj; Bruera, E; Clark-Snow, Ra; Dupuis, Ll; Einhorn, Lh; Feyer, P; Hesketh, Pj; Jordan, K; Olver, I; Rapoport, Bl; Roscoe, J; Ruhlmann, Ch; Walsh, D; Warr, D; van der Wetering, M | |
| Incidence, characteristics and treatment of fatigue in oncological cancer patients (pts) in italy: a cross-section study | 2016 | Roila, F; Spina, F; Ripamonti, C; Fumi, G; Antonuzzo, A; Cavanna, L; Gori, S; Mirabile, A; Fabi, A; Marzano, N; Graiff, C; De Sanctis, V; Serpentini, S; Bocci, C; Pino, Ms; Clienti, G; Verusio, C; Lutrino, Se; Fatigoni, S; Ballatori, E | |
| Anticipatory Nausea, Risk Factors, and Its Impact on Chemotherapy-Induced Nausea and Vomiting: Results From the Pan European Emesis Registry Study | 2016 | Molassiotis, A; Lee, Ph; Burke, Ta; Dicato, M; Gascon, P; Roila, F; Aapro, M | |
| Ginger in the management of chemotherapy induced nausea and vomiting (CINV), in patients receiving high dose cisplatin: a multicenter, randomized, double-blind, placebo-controlled study | 2016 | Bergamini, C; Bergamini, C; Cortinovis, D; Fatigoni, S; Rocca, Mc; Fabi, A; Iannace, A; Emiliani, A; Pessi, Ma; Ripamonti, Ci; Alfieri, S; Granata, R; Agustoni, F; Bidoli, P; Roila, F; Nole, F; Macchi, F; Michellini, L; Montanaro, F; Bossi, P | |
| Searching for evidence to support the use of ginger in the prevention of chemotherapy-induced nausea and vomiting | 2016 | Bossi, P; Cortinovis, D; Rocca, Mc; Roila, F; Seminara, P; Fabi, A; Canova, S; Verri, E; Fatigoni, S; Iannace, A; Macchi, F; Ripamonti, C | |
| Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain | 2016 | Bandieri, E; Romero, M; Ripamonti, Ci; Artioli, F; Sichetti, D; Fanizza, C; Santini, D; Cavanna, L; Melotti, B; Conte, Pf; Roila, F; Cascinu, S; Bruera, E; Tognoni, G; Luppi, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile